| 1 | people | 22,282 |
| 2 | australians | 161 |
| 3 | cdtq | 20 |
| 4 | ghanaians | 19 |
| 5 | ddtp | 11 |
| 6 | ontarians | 10 |
| 7 | iranians | 8 |
| 8 | community-dwellers | 7 |
| 9 | pakistanis | 7 |
| 10 | colombians | 5 |
| 11 | cu2znsns4 | 5 |
| 12 | latino/as | 5 |
| 13 | mbnps | 5 |
| 14 | actiniarians | 4 |
| 15 | californians | 4 |
| 16 | habitants | 4 |
| 17 | halophytes | 4 |
| 18 | cameroonians | 3 |
| 19 | levobupivacine | 3 |
| 20 | nano-objects | 3 |
| 21 | 2-oxindoles | 2 |
| 22 | 3-haloselenophenes | 2 |
| 23 | 3-nitro-2h-chromenes | 2 |
| 24 | 6,8-dibromo-4-chloroquinoline-3-carbaldehyde | 2 |
| 25 | agro-waste | 2 |
| 26 | alkynoates | 2 |
| 27 | bias.compared | 2 |
| 28 | calot | 2 |
| 29 | cetp-inhibition | 2 |
| 30 | dog-walking | 2 |
| 31 | hspa5mo | 2 |
| 32 | motorists | 2 |
| 33 | nitro-olefins | 2 |
| 34 | polymelia | 2 |
| 35 | rs651007 | 2 |
| 36 | ser29 | 2 |
| 37 | sws/onso/coupled | 2 |
| 38 | tatian | 2 |
| 39 | 'bag | 1 |
| 40 | 'deal | 1 |
| 41 | 0.05-1μg/ml | 1 |
| 42 | 0.137/h | 1 |
| 43 | 0.3-23 | 1 |
| 44 | 1,1,2,2-tetrasilyl-1,2-dilithiodisilane | 1 |
| 45 | 1,2:3,4-di-o-isopropylidine-α-d-galactopyranose | 1 |
| 46 | 1,3,5-trioxazatriquinanes | 1 |
| 47 | 1,3,7-octatrienes | 1 |
| 48 | 1,3-butadiynes | 1 |
| 49 | 1,7-enynes | 1 |
| 50 | 1-alkyl-5-nitro-1h-indazole | 1 |
| 51 | 1-bromo-3-chloropropene | 1 |
| 52 | 1-chloro-3-trimethylsilylcyclopropene | 1 |
| 53 | 1-hydroxyethylradicals | 1 |
| 54 | 1.7333 | 1 |
| 55 | 10-20g | 1 |
| 56 | 10-40-occured | 1 |
| 57 | 11-17-year-olds | 1 |
| 58 | 123s | 1 |
| 59 | 13c-phenylalanine | 1 |
| 60 | 17-113ml/minute | 1 |
| 61 | 1:1-2:3 | 1 |
| 62 | 2'-aminoacetophenones | 1 |
| 63 | 2'-hydroxymethylfluorescein | 1 |
| 64 | 2,2'-biimidazoles | 1 |
| 65 | 2,3,6,7,10,11-hexaaminotriphenylene | 1 |
| 66 | 2,3-dibromo-1-propenes | 1 |
| 67 | 2,4,6-triphenylphosphinine | 1 |
| 68 | 2,5-dibromo-3-hexylthiophene | 1 |
| 69 | 2,6-pyridinedicarboxaldehyde | 1 |
| 70 | 2-alkenoylpyridines | 1 |
| 71 | 2-amino-3,5-dibromobenzamide | 1 |
| 72 | 2-amino-n'-arylbenzohydrazides | 1 |
| 73 | 2-aminochromone-3-carboxaldehyde | 1 |
| 74 | 2-aryl-6-chloro-3,4-dihydroisoquinolin-2-iums | 1 |
| 75 | 2-benzyl-1,2,3-triazoles | 1 |
| 76 | 2-furylcarbinols | 1 |
| 77 | 2-mercapto-4-oxoquinazoline | 1 |
| 78 | 2-phenyl-5-methoxyoxazoles | 1 |
| 79 | 2-silyl-3,4-pyridynes | 1 |
| 80 | 2-vinylindoles | 1 |
| 81 | 2.3å | 1 |
| 82 | 2.4:5.0:2.6 | 1 |
| 83 | 23.5±0.5g/l | 1 |
| 84 | 250mers | 1 |
| 85 | 2a-e | 1 |
| 86 | 3,4-di-chloro-aniline | 1 |
| 87 | 3,4-diamino-1,2,5-oxadiazole | 1 |
| 88 | 3,4-diaminotriazole | 1 |
| 89 | 3,4-dimethoxybenzaldehyde | 1 |
| 90 | 3,4-dioxygenation | 1 |
| 91 | 3,5-di-tert-butyl-1,2-benzoquinone | 1 |
| 92 | 3-acetyl-4-hy-droxy-2h-chromen-2-one | 1 |
| 93 | 3-acetyl-4-hydroxy-α-pyrones | 1 |
| 94 | 3-bromo-3,3-difluoropropene | 1 |
| 95 | 3-chloroacrylate | 1 |
| 96 | 3-formyl-9-methylcarbazole | 1 |
| 97 | 3-hydoxyisoindolinones | 1 |
| 98 | 3-hydroxyoxindoles | 1 |
| 99 | 3-mefway | 1 |
| 100 | 3-pyrrolyl-oxindoles | 1 |
| 101 | 3-sulfolene | 1 |
| 102 | 3-wks | 1 |
| 103 | 32.5±1.6c | 1 |
| 104 | 35hu | 1 |
| 105 | 4'-chloro-2',5'-di-fluoro-aceto-phenone | 1 |
| 106 | 4-amino-1-methyl-3-propyl-1h-pyrazole-5-carboxamide | 1 |
| 107 | 4-amino-5-benzoyloisoxazolo-3-carboxamide | 1 |
| 108 | 4-chlorobutanoylisothiocyanate | 1 |
| 109 | 4-hydroxy-3-prenylbenzoate | 1 |
| 110 | 4-methoxyacetophenone | 1 |
| 111 | 4-methylbenzenesulfonylhydrazide | 1 |
| 112 | 4.1667 | 1 |
| 113 | 45.82mn | 1 |
| 114 | 48/h | 1 |
| 115 | 5'-azido-2'-oxa-3'-aza-4'a-carbanucleosides | 1 |
| 116 | 5,323 | 1 |
| 117 | 5-10mg/ml | 1 |
| 118 | 5-arylidene-4-thioxo-2-thiazolidinones | 1 |
| 119 | 5-chloro-1-phenyl-3-trifluoromethylpyrazole-4-carbaldehyde | 1 |
| 120 | 5-fluoro-2-deoxyuridine | 1 |
| 121 | 5-methylsalicylaldehyde | 1 |
| 122 | 5.636μg/ml | 1 |
| 123 | 6-8s | 1 |
| 124 | 7-aryl-1,6-enynes | 1 |
| 125 | 7.0-12.0 | 1 |
| 126 | 8.3448 | 1 |
| 127 | ac-d. | 1 |
| 128 | adultsaged | 1 |
| 129 | alkynes/allenes | 1 |
| 130 | allomin | 1 |
| 131 | allopatrically | 1 |
| 132 | aml-m4 | 1 |
| 133 | arene-1,4-diones | 1 |
| 134 | art.couples | 1 |
| 135 | aru+pru | 1 |
| 136 | as-men | 1 |
| 137 | asn-255 | 1 |
| 138 | autosuggestion | 1 |
| 139 | azidoalkyloxy-2h-chromen-2-ones | 1 |
| 140 | bif3 | 1 |
| 141 | bio-fluids | 1 |
| 142 | blasomeres | 1 |
| 143 | bmpp | 1 |
| 144 | bndz | 1 |
| 145 | bromobenzoquinones | 1 |
| 146 | but-2-yne-1,4-diols | 1 |
| 147 | c-phenyl-n-methylnitrone | 1 |
| 148 | c102cl20 | 1 |
| 149 | c8-carnitine | 1 |
| 150 | carbodithioates | 1 |
| 151 | cdk6/d1 | 1 |
| 152 | cf3ch2nh2 | 1 |
| 153 | chme | 1 |
| 154 | clustering.compared | 1 |
| 155 | co-nutrients | 1 |
| 156 | consultation.consistent | 1 |
| 157 | copd/aecb | 1 |
| 158 | crossfit™ | 1 |
| 159 | cs2mnf6 | 1 |
| 160 | csa-treatment | 1 |
| 161 | cycles/s | 1 |
| 162 | cyclopropylideneacetate | 1 |
| 163 | diazoacetamides | 1 |
| 164 | dibromoglyoxime | 1 |
| 165 | domains.participants | 1 |
| 166 | doxasosin | 1 |
| 167 | dr*04 | 1 |
| 168 | e-formularies | 1 |
| 169 | early-compared | 1 |
| 170 | educator-facilitators | 1 |
| 171 | end-plates | 1 |
| 172 | endvalues | 1 |
| 173 | eq/de≥0.018 | 1 |
| 174 | europium-allyl-3-carboxycoumarin | 1 |
| 175 | euros/year | 1 |
| 176 | evidence.consistent | 1 |
| 177 | fibrinogens | 1 |
| 178 | firs/funisitis | 1 |
| 179 | flukicides | 1 |
| 180 | fortimicin-a | 1 |
| 181 | freefalling | 1 |
| 182 | furan-2-carboxaldehyde | 1 |
| 183 | gan-wind | 1 |
| 184 | glu86 | 1 |
| 185 | gyrase-inhibitors | 1 |
| 186 | hamburg-altona | 1 |
| 187 | heteroexchange | 1 |
| 188 | home-therapy | 1 |
| 189 | honeycreepers | 1 |
| 190 | hrhpv-testing | 1 |
| 191 | hyperbase | 1 |
| 192 | ilora | 1 |
| 193 | impacts/collisions | 1 |
| 194 | indolin-3-ones | 1 |
| 195 | intense-dose | 1 |
| 196 | isatin-3-imines | 1 |
| 197 | isecp1b | 1 |
| 198 | isocyanoacetates | 1 |
| 199 | itselves | 1 |
| 200 | iv-glucagon | 1 |
| 201 | kc1 | 1 |
| 202 | khi2 | 1 |
| 203 | kilter | 1 |
| 204 | labour-amniotomy | 1 |
| 205 | lesions/vessels | 1 |
| 206 | long-durations | 1 |
| 207 | lpr/capsule | 1 |
| 208 | lprt | 1 |
| 209 | lygs | 1 |
| 210 | magea9 | 1 |
| 211 | meetings/conferences | 1 |
| 212 | metallodrugs | 1 |
| 213 | metallurgists | 1 |
| 214 | micro-contaminants | 1 |
| 215 | micro-tubes | 1 |
| 216 | mild-hyperkalemia | 1 |
| 217 | motts | 1 |
| 218 | myeloneuropathy | 1 |
| 219 | n-monoalkyl-1r,2r-diaminocylclohexanes | 1 |
| 220 | nano-pharmaceutics | 1 |
| 221 | nazism | 1 |
| 222 | neutrophilis | 1 |
| 223 | nme1/nme1l | 1 |
| 224 | o-vanillin | 1 |
| 225 | opd-ca-interviews | 1 |
| 226 | orfeomes | 1 |
| 227 | osb3 | 1 |
| 228 | overtreatments | 1 |
| 229 | oxpcs | 1 |
| 230 | p-tosylhydrazine | 1 |
| 231 | patients/episodes | 1 |
| 232 | patiets | 1 |
| 233 | pcdt/ta | 1 |
| 234 | penthoxyresorufin | 1 |
| 235 | petechiation | 1 |
| 236 | phcof | 1 |
| 237 | phenylthiol | 1 |
| 238 | phyto-components | 1 |
| 239 | phytoplasmas | 1 |
| 240 | piece-point | 1 |
| 241 | postlabelling | 1 |
| 242 | potatos | 1 |
| 243 | pyrrolecarbaldehydes | 1 |
| 244 | quinazolinocarbolines | 1 |
| 245 | rasayanas | 1 |
| 246 | rescuscitation | 1 |
| 247 | rhbua | 1 |
| 248 | rhodanines | 1 |
| 249 | ribostamycin/xylostasin | 1 |
| 250 | rm1089 | 1 |
| 251 | rub4 | 1 |
| 252 | satiety/hunger | 1 |
| 253 | screeningchildren | 1 |
| 254 | self-insufficiency | 1 |
| 255 | self-premedication | 1 |
| 256 | sheep/annum | 1 |
| 257 | sheeps | 1 |
| 258 | skin-fat-muscle | 1 |
| 259 | statokinesitherapy | 1 |
| 260 | strober | 1 |
| 261 | studies.prophylaxis | 1 |
| 262 | studies/subgroups | 1 |
| 263 | sulfonylacetylenes | 1 |
| 264 | survival-those | 1 |
| 265 | symptoms-differentiation | 1 |
| 266 | synchronization/breeding | 1 |
| 267 | t-anti-mirs | 1 |
| 268 | t-butylbenzamides | 1 |
| 269 | temperature-gradients | 1 |
| 270 | temperature-responsiveness | 1 |
| 271 | tgfβ/smad3 | 1 |
| 272 | theories/practices | 1 |
| 273 | therapies-beginning | 1 |
| 274 | to-knowing | 1 |
| 275 | totylfluanid | 1 |
| 276 | toujie | 1 |
| 277 | tricyanofluoroborates | 1 |
| 278 | tricyclization | 1 |
| 279 | trifluoromethanesulfanylamide | 1 |
| 280 | tube-sealing | 1 |
| 281 | turk-men | 1 |
| 282 | tussiculation | 1 |
| 283 | ua1b | 1 |
| 284 | val113 | 1 |
| 285 | ylideneoxindoles | 1 |
| 286 | yuthog | 1 |
| 287 | α-ketoamides | 1 |
| 288 | δepcs | 1 |
| 289 | €3.190.545 | 1 |
| 1 | 'bag | 1 |
| 2 | 'deal | 1 |
| 3 | 0.05-1μg/ml | 1 |
| 4 | 0.137/h | 1 |
| 5 | 0.3-23 | 1 |
| 6 | 1,1,2,2-tetrasilyl-1,2-dilithiodisilane | 1 |
| 7 | 1,2:3,4-di-o-isopropylidine-α-d-galactopyranose | 1 |
| 8 | 1,3,5-trioxazatriquinanes | 1 |
| 9 | 1,3,7-octatrienes | 1 |
| 10 | 1,3-butadiynes | 1 |
| 11 | 1,7-enynes | 1 |
| 12 | 1-alkyl-5-nitro-1h-indazole | 1 |
| 13 | 1-bromo-3-chloropropene | 1 |
| 14 | 1-chloro-3-trimethylsilylcyclopropene | 1 |
| 15 | 1-hydroxyethylradicals | 1 |
| 16 | 1.7333 | 1 |
| 17 | 10-20g | 1 |
| 18 | 10-40-occured | 1 |
| 19 | 11-17-year-olds | 1 |
| 20 | 123s | 1 |
| 21 | 13c-phenylalanine | 1 |
| 22 | 17-113ml/minute | 1 |
| 23 | 1:1-2:3 | 1 |
| 24 | 2'-aminoacetophenones | 1 |
| 25 | 2'-hydroxymethylfluorescein | 1 |
| 26 | 2,2'-biimidazoles | 1 |
| 27 | 2,3,6,7,10,11-hexaaminotriphenylene | 1 |
| 28 | 2,3-dibromo-1-propenes | 1 |
| 29 | 2,4,6-triphenylphosphinine | 1 |
| 30 | 2,5-dibromo-3-hexylthiophene | 1 |
| 31 | 2,6-pyridinedicarboxaldehyde | 1 |
| 32 | 2-alkenoylpyridines | 1 |
| 33 | 2-amino-3,5-dibromobenzamide | 1 |
| 34 | 2-amino-n'-arylbenzohydrazides | 1 |
| 35 | 2-aminochromone-3-carboxaldehyde | 1 |
| 36 | 2-aryl-6-chloro-3,4-dihydroisoquinolin-2-iums | 1 |
| 37 | 2-benzyl-1,2,3-triazoles | 1 |
| 38 | 2-furylcarbinols | 1 |
| 39 | 2-mercapto-4-oxoquinazoline | 1 |
| 40 | 2-oxindoles | 2 |
| 41 | 2-phenyl-5-methoxyoxazoles | 1 |
| 42 | 2-silyl-3,4-pyridynes | 1 |
| 43 | 2-vinylindoles | 1 |
| 44 | 2.3å | 1 |
| 45 | 2.4:5.0:2.6 | 1 |
| 46 | 23.5±0.5g/l | 1 |
| 47 | 250mers | 1 |
| 48 | 2a-e | 1 |
| 49 | 3,4-di-chloro-aniline | 1 |
| 50 | 3,4-diamino-1,2,5-oxadiazole | 1 |
| 51 | 3,4-diaminotriazole | 1 |
| 52 | 3,4-dimethoxybenzaldehyde | 1 |
| 53 | 3,4-dioxygenation | 1 |
| 54 | 3,5-di-tert-butyl-1,2-benzoquinone | 1 |
| 55 | 3-acetyl-4-hy-droxy-2h-chromen-2-one | 1 |
| 56 | 3-acetyl-4-hydroxy-α-pyrones | 1 |
| 57 | 3-bromo-3,3-difluoropropene | 1 |
| 58 | 3-chloroacrylate | 1 |
| 59 | 3-formyl-9-methylcarbazole | 1 |
| 60 | 3-haloselenophenes | 2 |
| 61 | 3-hydoxyisoindolinones | 1 |
| 62 | 3-hydroxyoxindoles | 1 |
| 63 | 3-mefway | 1 |
| 64 | 3-nitro-2h-chromenes | 2 |
| 65 | 3-pyrrolyl-oxindoles | 1 |
| 66 | 3-sulfolene | 1 |
| 67 | 3-wks | 1 |
| 68 | 32.5±1.6c | 1 |
| 69 | 35hu | 1 |
| 70 | 4'-chloro-2',5'-di-fluoro-aceto-phenone | 1 |
| 71 | 4-amino-1-methyl-3-propyl-1h-pyrazole-5-carboxamide | 1 |
| 72 | 4-amino-5-benzoyloisoxazolo-3-carboxamide | 1 |
| 73 | 4-chlorobutanoylisothiocyanate | 1 |
| 74 | 4-hydroxy-3-prenylbenzoate | 1 |
| 75 | 4-methoxyacetophenone | 1 |
| 76 | 4-methylbenzenesulfonylhydrazide | 1 |
| 77 | 4.1667 | 1 |
| 78 | 45.82mn | 1 |
| 79 | 48/h | 1 |
| 80 | 5'-azido-2'-oxa-3'-aza-4'a-carbanucleosides | 1 |
| 81 | 5,323 | 1 |
| 82 | 5-10mg/ml | 1 |
| 83 | 5-arylidene-4-thioxo-2-thiazolidinones | 1 |
| 84 | 5-chloro-1-phenyl-3-trifluoromethylpyrazole-4-carbaldehyde | 1 |
| 85 | 5-fluoro-2-deoxyuridine | 1 |
| 86 | 5-methylsalicylaldehyde | 1 |
| 87 | 5.636μg/ml | 1 |
| 88 | 6,8-dibromo-4-chloroquinoline-3-carbaldehyde | 2 |
| 89 | 6-8s | 1 |
| 90 | 7-aryl-1,6-enynes | 1 |
| 91 | 7.0-12.0 | 1 |
| 92 | 8.3448 | 1 |
| 93 | ac-d. | 1 |
| 94 | actiniarians | 4 |
| 95 | adultsaged | 1 |
| 96 | agro-waste | 2 |
| 97 | alkynes/allenes | 1 |
| 98 | alkynoates | 2 |
| 99 | allomin | 1 |
| 100 | allopatrically | 1 |
| 101 | aml-m4 | 1 |
| 102 | arene-1,4-diones | 1 |
| 103 | art.couples | 1 |
| 104 | aru+pru | 1 |
| 105 | as-men | 1 |
| 106 | asn-255 | 1 |
| 107 | australians | 161 |
| 108 | autosuggestion | 1 |
| 109 | azidoalkyloxy-2h-chromen-2-ones | 1 |
| 110 | bias.compared | 2 |
| 111 | bif3 | 1 |
| 112 | bio-fluids | 1 |
| 113 | blasomeres | 1 |
| 114 | bmpp | 1 |
| 115 | bndz | 1 |
| 116 | bromobenzoquinones | 1 |
| 117 | but-2-yne-1,4-diols | 1 |
| 118 | c-phenyl-n-methylnitrone | 1 |
| 119 | c102cl20 | 1 |
| 120 | c8-carnitine | 1 |
| 121 | californians | 4 |
| 122 | calot | 2 |
| 123 | cameroonians | 3 |
| 124 | carbodithioates | 1 |
| 125 | cdk6/d1 | 1 |
| 126 | cdtq | 20 |
| 127 | cetp-inhibition | 2 |
| 128 | cf3ch2nh2 | 1 |
| 129 | chme | 1 |
| 130 | clustering.compared | 1 |
| 131 | co-nutrients | 1 |
| 132 | colombians | 5 |
| 133 | community-dwellers | 7 |
| 134 | consultation.consistent | 1 |
| 135 | copd/aecb | 1 |
| 136 | crossfit™ | 1 |
| 137 | cs2mnf6 | 1 |
| 138 | csa-treatment | 1 |
| 139 | cu2znsns4 | 5 |
| 140 | cycles/s | 1 |
| 141 | cyclopropylideneacetate | 1 |
| 142 | ddtp | 11 |
| 143 | diazoacetamides | 1 |
| 144 | dibromoglyoxime | 1 |
| 145 | dog-walking | 2 |
| 146 | domains.participants | 1 |
| 147 | doxasosin | 1 |
| 148 | dr*04 | 1 |
| 149 | e-formularies | 1 |
| 150 | early-compared | 1 |
| 151 | educator-facilitators | 1 |
| 152 | end-plates | 1 |
| 153 | endvalues | 1 |
| 154 | eq/de≥0.018 | 1 |
| 155 | europium-allyl-3-carboxycoumarin | 1 |
| 156 | euros/year | 1 |
| 157 | evidence.consistent | 1 |
| 158 | fibrinogens | 1 |
| 159 | firs/funisitis | 1 |
| 160 | flukicides | 1 |
| 161 | fortimicin-a | 1 |
| 162 | freefalling | 1 |
| 163 | furan-2-carboxaldehyde | 1 |
| 164 | gan-wind | 1 |
| 165 | ghanaians | 19 |
| 166 | glu86 | 1 |
| 167 | gyrase-inhibitors | 1 |
| 168 | habitants | 4 |
| 169 | halophytes | 4 |
| 170 | hamburg-altona | 1 |
| 171 | heteroexchange | 1 |
| 172 | home-therapy | 1 |
| 173 | honeycreepers | 1 |
| 174 | hrhpv-testing | 1 |
| 175 | hspa5mo | 2 |
| 176 | hyperbase | 1 |
| 177 | ilora | 1 |
| 178 | impacts/collisions | 1 |
| 179 | indolin-3-ones | 1 |
| 180 | intense-dose | 1 |
| 181 | iranians | 8 |
| 182 | isatin-3-imines | 1 |
| 183 | isecp1b | 1 |
| 184 | isocyanoacetates | 1 |
| 185 | itselves | 1 |
| 186 | iv-glucagon | 1 |
| 187 | kc1 | 1 |
| 188 | khi2 | 1 |
| 189 | kilter | 1 |
| 190 | labour-amniotomy | 1 |
| 191 | latino/as | 5 |
| 192 | lesions/vessels | 1 |
| 193 | levobupivacine | 3 |
| 194 | long-durations | 1 |
| 195 | lpr/capsule | 1 |
| 196 | lprt | 1 |
| 197 | lygs | 1 |
| 198 | magea9 | 1 |
| 199 | mbnps | 5 |
| 200 | meetings/conferences | 1 |
| 201 | metallodrugs | 1 |
| 202 | metallurgists | 1 |
| 203 | micro-contaminants | 1 |
| 204 | micro-tubes | 1 |
| 205 | mild-hyperkalemia | 1 |
| 206 | motorists | 2 |
| 207 | motts | 1 |
| 208 | myeloneuropathy | 1 |
| 209 | n-monoalkyl-1r,2r-diaminocylclohexanes | 1 |
| 210 | nano-objects | 3 |
| 211 | nano-pharmaceutics | 1 |
| 212 | nazism | 1 |
| 213 | neutrophilis | 1 |
| 214 | nitro-olefins | 2 |
| 215 | nme1/nme1l | 1 |
| 216 | o-vanillin | 1 |
| 217 | ontarians | 10 |
| 218 | opd-ca-interviews | 1 |
| 219 | orfeomes | 1 |
| 220 | osb3 | 1 |
| 221 | overtreatments | 1 |
| 222 | oxpcs | 1 |
| 223 | p-tosylhydrazine | 1 |
| 224 | pakistanis | 7 |
| 225 | patients/episodes | 1 |
| 226 | patiets | 1 |
| 227 | pcdt/ta | 1 |
| 228 | penthoxyresorufin | 1 |
| 229 | people | 22,282 |
| 230 | petechiation | 1 |
| 231 | phcof | 1 |
| 232 | phenylthiol | 1 |
| 233 | phyto-components | 1 |
| 234 | phytoplasmas | 1 |
| 235 | piece-point | 1 |
| 236 | polymelia | 2 |
| 237 | postlabelling | 1 |
| 238 | potatos | 1 |
| 239 | pyrrolecarbaldehydes | 1 |
| 240 | quinazolinocarbolines | 1 |
| 241 | rasayanas | 1 |
| 242 | rescuscitation | 1 |
| 243 | rhbua | 1 |
| 244 | rhodanines | 1 |
| 245 | ribostamycin/xylostasin | 1 |
| 246 | rm1089 | 1 |
| 247 | rs651007 | 2 |
| 248 | rub4 | 1 |
| 249 | satiety/hunger | 1 |
| 250 | screeningchildren | 1 |
| 251 | self-insufficiency | 1 |
| 252 | self-premedication | 1 |
| 253 | ser29 | 2 |
| 254 | sheep/annum | 1 |
| 255 | sheeps | 1 |
| 256 | skin-fat-muscle | 1 |
| 257 | statokinesitherapy | 1 |
| 258 | strober | 1 |
| 259 | studies.prophylaxis | 1 |
| 260 | studies/subgroups | 1 |
| 261 | sulfonylacetylenes | 1 |
| 262 | survival-those | 1 |
| 263 | sws/onso/coupled | 2 |
| 264 | symptoms-differentiation | 1 |
| 265 | synchronization/breeding | 1 |
| 266 | t-anti-mirs | 1 |
| 267 | t-butylbenzamides | 1 |
| 268 | tatian | 2 |
| 269 | temperature-gradients | 1 |
| 270 | temperature-responsiveness | 1 |
| 271 | tgfβ/smad3 | 1 |
| 272 | theories/practices | 1 |
| 273 | therapies-beginning | 1 |
| 274 | to-knowing | 1 |
| 275 | totylfluanid | 1 |
| 276 | toujie | 1 |
| 277 | tricyanofluoroborates | 1 |
| 278 | tricyclization | 1 |
| 279 | trifluoromethanesulfanylamide | 1 |
| 280 | tube-sealing | 1 |
| 281 | turk-men | 1 |
| 282 | tussiculation | 1 |
| 283 | ua1b | 1 |
| 284 | val113 | 1 |
| 285 | ylideneoxindoles | 1 |
| 286 | yuthog | 1 |
| 287 | α-ketoamides | 1 |
| 288 | δepcs | 1 |
| 289 | €3.190.545 | 1 |
| 1 | ac-d. | 1 |
| 2 | 7.0-12.0 | 1 |
| 3 | c102cl20 | 1 |
| 4 | kc1 | 1 |
| 5 | cdk6/d1 | 1 |
| 6 | cf3ch2nh2 | 1 |
| 7 | khi2 | 1 |
| 8 | val113 | 1 |
| 9 | 0.3-23 | 1 |
| 10 | 5,323 | 1 |
| 11 | 1.7333 | 1 |
| 12 | 1:1-2:3 | 1 |
| 13 | osb3 | 1 |
| 14 | tgfβ/smad3 | 1 |
| 15 | bif3 | 1 |
| 16 | dr*04 | 1 |
| 17 | rub4 | 1 |
| 18 | aml-m4 | 1 |
| 19 | cu2znsns4 | 5 |
| 20 | €3.190.545 | 1 |
| 21 | asn-255 | 1 |
| 22 | 2.4:5.0:2.6 | 1 |
| 23 | glu86 | 1 |
| 24 | cs2mnf6 | 1 |
| 25 | rs651007 | 2 |
| 26 | 4.1667 | 1 |
| 27 | eq/de≥0.018 | 1 |
| 28 | 8.3448 | 1 |
| 29 | ser29 | 2 |
| 30 | rm1089 | 1 |
| 31 | magea9 | 1 |
| 32 | fortimicin-a | 1 |
| 33 | polymelia | 2 |
| 34 | mild-hyperkalemia | 1 |
| 35 | hamburg-altona | 1 |
| 36 | ilora | 1 |
| 37 | pcdt/ta | 1 |
| 38 | rhbua | 1 |
| 39 | ua1b | 1 |
| 40 | isecp1b | 1 |
| 41 | copd/aecb | 1 |
| 42 | 32.5±1.6c | 1 |
| 43 | adultsaged | 1 |
| 44 | sws/onso/coupled | 2 |
| 45 | early-compared | 1 |
| 46 | clustering.compared | 1 |
| 47 | bias.compared | 2 |
| 48 | 10-40-occured | 1 |
| 49 | totylfluanid | 1 |
| 50 | gan-wind | 1 |
| 51 | 2a-e | 1 |
| 52 | trifluoromethanesulfanylamide | 1 |
| 53 | 4-amino-5-benzoyloisoxazolo-3-carboxamide | 1 |
| 54 | 4-amino-1-methyl-3-propyl-1h-pyrazole-5-carboxamide | 1 |
| 55 | 2-amino-3,5-dibromobenzamide | 1 |
| 56 | 4-methylbenzenesulfonylhydrazide | 1 |
| 57 | 6,8-dibromo-4-chloroquinoline-3-carbaldehyde | 2 |
| 58 | 5-chloro-1-phenyl-3-trifluoromethylpyrazole-4-carbaldehyde | 1 |
| 59 | 5-methylsalicylaldehyde | 1 |
| 60 | furan-2-carboxaldehyde | 1 |
| 61 | 2-aminochromone-3-carboxaldehyde | 1 |
| 62 | 2,6-pyridinedicarboxaldehyde | 1 |
| 63 | 3,4-dimethoxybenzaldehyde | 1 |
| 64 | heteroexchange | 1 |
| 65 | toujie | 1 |
| 66 | skin-fat-muscle | 1 |
| 67 | 3-formyl-9-methylcarbazole | 1 |
| 68 | 1-alkyl-5-nitro-1h-indazole | 1 |
| 69 | 3,4-diamino-1,2,5-oxadiazole | 1 |
| 70 | 3,4-diaminotriazole | 1 |
| 71 | people | 22,282 |
| 72 | lpr/capsule | 1 |
| 73 | chme | 1 |
| 74 | dibromoglyoxime | 1 |
| 75 | 1,1,2,2-tetrasilyl-1,2-dilithiodisilane | 1 |
| 76 | 2,5-dibromo-3-hexylthiophene | 1 |
| 77 | 3-sulfolene | 1 |
| 78 | 2,3,6,7,10,11-hexaaminotriphenylene | 1 |
| 79 | 1-chloro-3-trimethylsilylcyclopropene | 1 |
| 80 | 1-bromo-3-chloropropene | 1 |
| 81 | 3-bromo-3,3-difluoropropene | 1 |
| 82 | levobupivacine | 3 |
| 83 | 5-fluoro-2-deoxyuridine | 1 |
| 84 | 3,4-di-chloro-aniline | 1 |
| 85 | 2-mercapto-4-oxoquinazoline | 1 |
| 86 | 13c-phenylalanine | 1 |
| 87 | 2,4,6-triphenylphosphinine | 1 |
| 88 | c8-carnitine | 1 |
| 89 | p-tosylhydrazine | 1 |
| 90 | 3-acetyl-4-hy-droxy-2h-chromen-2-one | 1 |
| 91 | 4'-chloro-2',5'-di-fluoro-aceto-phenone | 1 |
| 92 | 4-methoxyacetophenone | 1 |
| 93 | 3,5-di-tert-butyl-1,2-benzoquinone | 1 |
| 94 | c-phenyl-n-methylnitrone | 1 |
| 95 | hyperbase | 1 |
| 96 | intense-dose | 1 |
| 97 | survival-those | 1 |
| 98 | 1,2:3,4-di-o-isopropylidine-α-d-galactopyranose | 1 |
| 99 | 3-chloroacrylate | 1 |
| 100 | 4-chlorobutanoylisothiocyanate | 1 |
| 101 | 4-hydroxy-3-prenylbenzoate | 1 |
| 102 | cyclopropylideneacetate | 1 |
| 103 | agro-waste | 2 |
| 104 | 17-113ml/minute | 1 |
| 105 | phcof | 1 |
| 106 | 10-20g | 1 |
| 107 | 'bag | 1 |
| 108 | synchronization/breeding | 1 |
| 109 | dog-walking | 2 |
| 110 | tube-sealing | 1 |
| 111 | freefalling | 1 |
| 112 | postlabelling | 1 |
| 113 | therapies-beginning | 1 |
| 114 | hrhpv-testing | 1 |
| 115 | to-knowing | 1 |
| 116 | yuthog | 1 |
| 117 | 0.137/h | 1 |
| 118 | 48/h | 1 |
| 119 | 23.5±0.5g/l | 1 |
| 120 | nme1/nme1l | 1 |
| 121 | 'deal | 1 |
| 122 | 5-10mg/ml | 1 |
| 123 | 0.05-1μg/ml | 1 |
| 124 | 5.636μg/ml | 1 |
| 125 | phenylthiol | 1 |
| 126 | nazism | 1 |
| 127 | sheep/annum | 1 |
| 128 | tatian | 2 |
| 129 | turk-men | 1 |
| 130 | as-men | 1 |
| 131 | screeningchildren | 1 |
| 132 | 2'-hydroxymethylfluorescein | 1 |
| 133 | penthoxyresorufin | 1 |
| 134 | o-vanillin | 1 |
| 135 | allomin | 1 |
| 136 | europium-allyl-3-carboxycoumarin | 1 |
| 137 | ribostamycin/xylostasin | 1 |
| 138 | doxasosin | 1 |
| 139 | 45.82mn | 1 |
| 140 | iv-glucagon | 1 |
| 141 | self-premedication | 1 |
| 142 | petechiation | 1 |
| 143 | symptoms-differentiation | 1 |
| 144 | tussiculation | 1 |
| 145 | 3,4-dioxygenation | 1 |
| 146 | rescuscitation | 1 |
| 147 | tricyclization | 1 |
| 148 | cetp-inhibition | 2 |
| 149 | autosuggestion | 1 |
| 150 | hspa5mo | 2 |
| 151 | bmpp | 1 |
| 152 | ddtp | 11 |
| 153 | cdtq | 20 |
| 154 | euros/year | 1 |
| 155 | strober | 1 |
| 156 | satiety/hunger | 1 |
| 157 | kilter | 1 |
| 158 | cycles/s | 1 |
| 159 | 123s | 1 |
| 160 | 6-8s | 1 |
| 161 | latino/as | 5 |
| 162 | phytoplasmas | 1 |
| 163 | rasayanas | 1 |
| 164 | nano-pharmaceutics | 1 |
| 165 | δepcs | 1 |
| 166 | oxpcs | 1 |
| 167 | bio-fluids | 1 |
| 168 | 11-17-year-olds | 1 |
| 169 | micro-tubes | 1 |
| 170 | theories/practices | 1 |
| 171 | meetings/conferences | 1 |
| 172 | flukicides | 1 |
| 173 | α-ketoamides | 1 |
| 174 | diazoacetamides | 1 |
| 175 | t-butylbenzamides | 1 |
| 176 | 5'-azido-2'-oxa-3'-aza-4'a-carbanucleosides | 1 |
| 177 | 2-amino-n'-arylbenzohydrazides | 1 |
| 178 | patients/episodes | 1 |
| 179 | pyrrolecarbaldehydes | 1 |
| 180 | e-formularies | 1 |
| 181 | 2-vinylindoles | 1 |
| 182 | 2-oxindoles | 2 |
| 183 | 3-pyrrolyl-oxindoles | 1 |
| 184 | ylideneoxindoles | 1 |
| 185 | 3-hydroxyoxindoles | 1 |
| 186 | 2,2'-biimidazoles | 1 |
| 187 | 2-benzyl-1,2,3-triazoles | 1 |
| 188 | 2-phenyl-5-methoxyoxazoles | 1 |
| 189 | art.couples | 1 |
| 190 | orfeomes | 1 |
| 191 | 1,3,5-trioxazatriquinanes | 1 |
| 192 | n-monoalkyl-1r,2r-diaminocylclohexanes | 1 |
| 193 | 3-haloselenophenes | 2 |
| 194 | 1,3,7-octatrienes | 1 |
| 195 | alkynes/allenes | 1 |
| 196 | sulfonylacetylenes | 1 |
| 197 | 3-nitro-2h-chromenes | 2 |
| 198 | 2,3-dibromo-1-propenes | 1 |
| 199 | 2-alkenoylpyridines | 1 |
| 200 | quinazolinocarbolines | 1 |
| 201 | isatin-3-imines | 1 |
| 202 | rhodanines | 1 |
| 203 | azidoalkyloxy-2h-chromen-2-ones | 1 |
| 204 | indolin-3-ones | 1 |
| 205 | arene-1,4-diones | 1 |
| 206 | 2'-aminoacetophenones | 1 |
| 207 | 5-arylidene-4-thioxo-2-thiazolidinones | 1 |
| 208 | 3-hydoxyisoindolinones | 1 |
| 209 | bromobenzoquinones | 1 |
| 210 | 3-acetyl-4-hydroxy-α-pyrones | 1 |
| 211 | 2-silyl-3,4-pyridynes | 1 |
| 212 | 1,3-butadiynes | 1 |
| 213 | 7-aryl-1,6-enynes | 1 |
| 214 | 1,7-enynes | 1 |
| 215 | blasomeres | 1 |
| 216 | end-plates | 1 |
| 217 | carbodithioates | 1 |
| 218 | alkynoates | 2 |
| 219 | tricyanofluoroborates | 1 |
| 220 | isocyanoacetates | 1 |
| 221 | halophytes | 4 |
| 222 | endvalues | 1 |
| 223 | itselves | 1 |
| 224 | metallodrugs | 1 |
| 225 | lygs | 1 |
| 226 | neutrophilis | 1 |
| 227 | pakistanis | 7 |
| 228 | firs/funisitis | 1 |
| 229 | studies.prophylaxis | 1 |
| 230 | 3-wks | 1 |
| 231 | 1-hydroxyethylradicals | 1 |
| 232 | lesions/vessels | 1 |
| 233 | but-2-yne-1,4-diols | 1 |
| 234 | 2-furylcarbinols | 1 |
| 235 | 2-aryl-6-chloro-3,4-dihydroisoquinolin-2-iums | 1 |
| 236 | ghanaians | 19 |
| 237 | colombians | 5 |
| 238 | australians | 161 |
| 239 | iranians | 8 |
| 240 | cameroonians | 3 |
| 241 | californians | 4 |
| 242 | actiniarians | 4 |
| 243 | ontarians | 10 |
| 244 | fibrinogens | 1 |
| 245 | nitro-olefins | 2 |
| 246 | impacts/collisions | 1 |
| 247 | long-durations | 1 |
| 248 | potatos | 1 |
| 249 | sheeps | 1 |
| 250 | mbnps | 5 |
| 251 | studies/subgroups | 1 |
| 252 | community-dwellers | 7 |
| 253 | 250mers | 1 |
| 254 | honeycreepers | 1 |
| 255 | t-anti-mirs | 1 |
| 256 | educator-facilitators | 1 |
| 257 | gyrase-inhibitors | 1 |
| 258 | temperature-responsiveness | 1 |
| 259 | nano-objects | 3 |
| 260 | patiets | 1 |
| 261 | micro-contaminants | 1 |
| 262 | domains.participants | 1 |
| 263 | habitants | 4 |
| 264 | temperature-gradients | 1 |
| 265 | co-nutrients | 1 |
| 266 | overtreatments | 1 |
| 267 | phyto-components | 1 |
| 268 | metallurgists | 1 |
| 269 | motorists | 2 |
| 270 | motts | 1 |
| 271 | opd-ca-interviews | 1 |
| 272 | csa-treatment | 1 |
| 273 | evidence.consistent | 1 |
| 274 | consultation.consistent | 1 |
| 275 | piece-point | 1 |
| 276 | calot | 2 |
| 277 | lprt | 1 |
| 278 | 35hu | 1 |
| 279 | aru+pru | 1 |
| 280 | 3-mefway | 1 |
| 281 | self-insufficiency | 1 |
| 282 | myeloneuropathy | 1 |
| 283 | allopatrically | 1 |
| 284 | labour-amniotomy | 1 |
| 285 | home-therapy | 1 |
| 286 | statokinesitherapy | 1 |
| 287 | bndz | 1 |
| 288 | crossfit™ | 1 |
| 289 | 2.3å | 1 |